tiprankstipranks
Trending News
More News >
Guided Therapeutics (GTHP)
:GTHP
US Market
Advertisement

Guided Therapeutics (GTHP) Technical Analysis

Compare
24 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Guided Therapeutics’s (GTHP) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Guided Therapeutics is a Buy.
Guided Therapeutics’s (GTHP) 20-Day exponential moving average is 0.24, while Guided Therapeutics’s (GTHP) share price is $0.24, making it a Sell.
Guided Therapeutics’s (GTHP) 50-Day exponential moving average is 0.21, while Guided Therapeutics’s (GTHP) share price is $0.24, making it a Buy.

Guided Therapeutics (GTHP) Pivot Points

Jul 24, 2025, 09:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.21
0.22
0.23
0.23
0.24
0.25
0.26
Fibonacci
0.22
0.22
0.23
0.23
0.24
0.24
0.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Guided Therapeutics (GTHP) Moving Averages

Jul 24, 2025, 09:34 AM
Period
Simple
Exponential
MA5
0.25Sell
0.25Sell
MA10
0.25Sell
0.25Sell
MA20
0.26Sell
0.24Sell
MA50
0.19Buy
0.21Buy
MA100
0.15Buy
0.17Buy
MA200
0.15Buy
0.16Buy
Guided Therapeutics’s (GTHP) 10-Day exponential moving average is 0.25, while Guided Therapeutics’s (GTHP) share price is $0.24, making it a Sell.
Guided Therapeutics’s (GTHP) 100-Day exponential moving average is 0.17, while Guided Therapeutics’s (GTHP) share price is $0.24, making it a Buy.
Guided Therapeutics’s (GTHP) stock price is $0.24 and Guided Therapeutics’s (GTHP) 50-day simple moving average is 0.19, creating a Buy signal.
Guided Therapeutics’s (GTHP) stock price is $0.24 and Guided Therapeutics’s (GTHP) 100-day simple moving average is 0.15, creating a Buy signal.
Guided Therapeutics’s (GTHP) stock price is $0.24 and Guided Therapeutics’s (GTHP) 200-day simple moving average is 0.15, creating a Buy signal.

Guided Therapeutics (GTHP) Technical Indicators

Jul 24, 2025, 09:34 AM
Name
Value
Implied Action
RSI (14)
52.12
Neutral
STOCH (9,6)
55.90
Neutral
STOCHRSI (14)
40.40
Neutral
MACD (12,26)
0.01
Buy
ADX (14)
15.15
Buy
Williams %R
-62.12
Buy
CCI (14)
-59.94
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
85.44
Buy
ROC
4.35
Buy
Guided Therapeutics’s (GTHP) Relative Strength Index (RSI) is 52.12, creating a Neutral signal.
Guided Therapeutics’s (GTHP) Trend Strength Indicator (ADX) is 15.15, creating a Buy signal.
Guided Therapeutics’s (GTHP) Commodity Channel Index (CCI) is -59.94, creating a Neutral signal.
Guided Therapeutics’s (GTHP) Price Rate of Change (ROC) is 4.35, creating a Buy signal.

FAQ

Is GTHP a Buy, Hold, or Sell?
Based on GTHP’s technical indicators, GTHP is a Buy.
    What is GTHP’s RSI (14)?
    GTHP’s RSI (14) is 52.12, which suggests GTHP is a Neutral.
      What is GTHP’s MACD?
      GTHP’s MACD is 0.01, which suggests GTHP is a Buy.
        What is GTHP’s 5-day moving average?
        GTHP’s 5-day moving average is 0.25, which suggests GTHP is a Sell.
          What is GTHP’s 20-day moving average?
          GTHP 20-day moving average is 0.26, which suggests GTHP is a Sell.
            What is GTHP’s 50-day moving average?
            GTHP’s 50-day moving average is 0.19, which suggests GTHP is a Buy.
              What is GTHP’s 200-day moving average?
              GTHP’s 200-day moving average is 0.15, which suggests GTHP is a Buy.
                What is GTHP’s Williams % R (14)?
                GTHP’s Williams % R (14) is -62.12, which suggests GTHP is a Buy.
                  What is GTHP’s CCI (14)?
                  GTHP’s CCI (14) is -59.94, which suggests GTHP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis